Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy. (28th March 2021) - Maglie, R.; Ugolini, F.; De Logu, F.; Simi, S.; Senatore, S.; Montefusco, F.; Nassini, R.; Massi, D.; Antiga, E.